Jarritos® Rolls Out Mandarin Zero Nationwide
Iconic soda brand delivers its top-selling flavor with zero calories
EL PASO,
The launch of Mandarin Zero underscores Jarritos' commitment to evolving with consumer preferences while maintaining the brand's hallmark fruit-forward authenticity. Marking its 75th anniversary this year, Jarritos introduces its first zero-calorie flavor to go nationwide.
To ensure Mandarin Zero delivered the same experience as the original, Jarritos conducted extensive consumer research. In blind taste tests with over 1,000 participants, consumers could not distinguish between Mandarin Zero and the flagship Mandarin flavor. Both beverages offered the same bold aroma, refreshing taste, and signature citrus kick they know and love.
"Fans have asked for a Jarritos option that fits zero-calorie lifestyles without losing the real fruit taste they love," says
Jarritos Mandarin Zero is rapidly scaling distribution, with placement in approximately 4,500 retail doors nationwide by
The product launch is supported by a new integrated platform: "Jarritos Zero. More of What You Love." The campaign will feature digital media, influencer activations, and paid social, with out-of-home placements launching in
To learn more about Jarritos and find out where to try Jarritos Mandarin Zero, visit https://jarritos.com/.
About Jarritos
Created in 1950, Jarritos are delicious fruit-flavored sodas from
Press Release Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/jarritos-rolls-out-mandarin-zero-nationwide-302570389.html
SOURCE Jarritos
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SweetNight Launches The Cooling Recovery Campaign, Offering Exclusive Cooling Kits to Support Summer Sleep and Recovery
- Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older
- Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share